Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants

PHASE3RecruitingINTERVENTIONAL
Enrollment

783

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Breast Reconstruction
Interventions
DEVICE

ARTIA Reconstructive Tissue Matrix

Surgical Implant

OTHER

No Intervention

No ADM

Trial Locations (13)

22903

RECRUITING

University of Virginia /ID# 265098, Charlottesville

32610

RECRUITING

University of Florida College of Medicine /ID# 267485, Gainesville

37403

RECRUITING

Erlanger Health System /ID# 266608, Chattanooga

43202

RECRUITING

Ohio State University Comprehensive Cancer Center /ID# 266253, Columbus

63130

RECRUITING

Washington University School of Medicine - St. Louis /ID# 264029, St Louis

77030

RECRUITING

The University of Texas MD Anderson Cancer Center /ID# 264020, Houston

89154

RECRUITING

University of Nevada - Main Campus /ID# 264017, Las Vegas

90505

RECRUITING

South Bay Plastic Surgeons /ID# 264192, Torrance

98660

RECRUITING

AG Aesthetic Center /ID# 264233, Vancouver

92868-3201

RECRUITING

UC Irvine Medical Center /ID# 267428, Orange

60062-2802

RECRUITING

Endeavor Health /ID# 266302, Northbrook

07103

RECRUITING

Rutgers New Jersey Medical School - Newark /ID# 264187, Newark

10016-6402

COMPLETED

NYU Langone Medical Center /ID# 265621, New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY